Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | ALB | P02768 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | PNP | P00491 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.49 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.49 |
| ▸ | ADA | P00813 | 1/20 | 0.45 |
| ▸ | NT5E | P21589 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.42 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3239663 | 0.89 | LMNA (0.59) | LMNAALDH1A1ALBMAPK1CYP1A2 | |
| SCHEMBL25712959 | 0.89 | LMNA (0.59) | LMNAALDH1A1ALBMAPK1CYP1A2 | |
| SCHEMBL3054167 | 0.87 | LMNA (0.58) | LMNAALDH1A1ALBMAPK1CYP1A2 | |
| SCHEMBL5548925 | 0.87 | LMNA (0.57) | LMNAALDH1A1ALBMAPK1CYP1A2 | |
| SCHEMBL22862138 | 0.87 | LMNA (0.58) | LMNAALDH1A1ALBMAPK1CYP1A2 | |
| SCHEMBL9601706 | 0.87 | LMNA (0.57) | LMNAALDH1A1ALBMAPK1CYP1A2 | |
| SCHEMBL8124562 | 0.87 | LMNA (0.65) | LMNAALDH1A1ALBMAPK1CYP1A2 | |
| SCHEMBL2808298 | 0.87 | LMNA (0.58) | LMNAALDH1A1ALBMAPK1CYP1A2 | |
| SCHEMBL30694424 | 0.87 | LMNA (0.65) | LMNAALDH1A1ALBMAPK1CYP1A2 | |
| SCHEMBL19242566 | 0.87 | LMNA (0.65) | LMNAALDH1A1ALBMAPK1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0355135-A4 | ADENOSINE DEAMINASE-STABLE ANTI-RETROVIRAL NUCLEOSIDES. | SCRIPPS CLINIC RES (US) | 1990-04-09 | — | — | EP | claimed |
| EP-0355135-A1 | ADENOSINE DEAMINASE-STABLE ANTI-RETROVIRAL NUCLEOSIDES | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1990-02-28 | — | — | EP | claimed |
| WO-1989004662-A1 | ADENOSINE DEAMINASE-STABLE ANTI-RETROVIRAL NUCLEOSIDES | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1989-06-01 | — | — | WO | claimed |
| US-5580860-A | ANTI-AIDS VIRICIDE | SANYO KOKUSAKU PULP CO., LTD. (JP) | 1996-12-03 | — | — | US | disclosed |
| US-5512671-A | VIRICIDES | WAKE FOREST UNIVERSITY (US) | 1996-04-30 | — | — | US | disclosed |
| EP-0533825-B1 | ETHER LIPID-NUCLEOSIDE COVALENT CONJUGATES | UNIV WAKE FOREST (US) | 1996-04-24 | — | — | EP | disclosed |
| EP-0355135-B1 | ADENOSINE DEAMINASE-STABLE ANTI-RETROVIRAL NUCLEOSIDES | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1993-08-04 | — | — | EP | disclosed |
| WO-1993002692-A1 | METHOD OF COMBATTING HIV INFECTIONS | DUKE UNIVERSITY (US) | 1993-02-18 | — | — | WO | disclosed |
| WO-1991019726-A1 | ETHER LIPID-NUCLEOSIDE COVALENT CONJUGATES | WAKE FOREST UNIVERSITY (US) | 1991-12-26 | — | — | WO | disclosed |
| US-4997926-A | Viricides | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1991-03-05 | — | — | US | disclosed |
| EP-0355135-A4 | ADENOSINE DEAMINASE-STABLE ANTI-RETROVIRAL NUCLEOSIDES. | SCRIPPS CLINIC RES (US) | 1990-04-09 | — | — | EP | disclosed |
| EP-0355135-A1 | ADENOSINE DEAMINASE-STABLE ANTI-RETROVIRAL NUCLEOSIDES | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1990-02-28 | — | — | EP | disclosed |
| WO-1989004662-A1 | ADENOSINE DEAMINASE-STABLE ANTI-RETROVIRAL NUCLEOSIDES | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1989-06-01 | — | — | WO | disclosed |